In 2009, Rhode Island’s front-line researchers formed the Rhode Island Consortium for Autism Research and Treatment (RI-CART) to explore how physicians, scientists, service providers, educators and parents could collaborate on a broad range of research projects - ranging from animal to human, genetic to cellular, clinical imaging to treatment outcomes, and family and education-related research.
The U.S. Centers for Disease Control and Prevention estimates that one in 88 children in the United States are diagnosed with autism; more than one million children in the U.S. are directly affected by autism.
Because of its prevalence and impact on society, autism spectrum disorders (ASDs) require intensive and integrated scientific research.
RI-CART has evolved into a unique, public-private partnership that includes the state’s leading experts on autism research education, health and advocacy.
RI-CART members share a strong belief: the best way to create healthier, happier lives for individuals with ASDs is to expand our knowledge. RI-CART meets its mission through widespread, rigorous testing; collaborative, creative research; and inclusive, data-driven education and advocacy.
This belief in the power of knowledge and the importance of partnerships drives RI-CART’s long-term goal of enrolling all Rhode Islanders with an ASD into a web-based registry by 2020.